Trial
NCT06974734
A Clinical Trial of PF-08046037 Alone or With Sasanlimab in Patients With Advanced or Metastatic Malignancies
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Pfizer
Collaborators
—
Condition
Carcinoma, Non Small Cell Lung
Intervention
PF-08046037
Why stopped
The trial was terminated for strategic business reasons; the decision was not based on any safety and/or efficacy concerns
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-04-23